{
  "trial_id": "NCT02414529",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "obese subjects",
      "label": "met",
      "evidence": "BMI at or above the 95th percentile for children of the same age and sex"
    },
    {
      "criterion": "pubertal",
      "label": "met",
      "evidence": "Testicular volume \u2265 6 ml Prader (M) and Tanner III breast development or greater (F)"
    },
    {
      "criterion": "age",
      "label": "met",
      "evidence": "12- 18 years regardless of gender, race or economic circumstance"
    },
    {
      "criterion": "pre diabetes/high risk of diabetes",
      "label": "met",
      "evidence": "HbA1C between 5.7 - 6.4% as defined by the American Diabetes Association (ADA)"
    },
    {
      "criterion": "25-OH vitamin D level less than 20 ng/ml",
      "label": "met",
      "evidence": "less than 20 ng/ml (50 nmol/liter)"
    },
    {
      "criterion": "willingness to comply with study protocol requirements",
      "label": "met",
      "evidence": "Subjects must be willing to comply with study protocol requirements"
    },
    {
      "criterion": "obese subjects",
      "label": "met",
      "evidence": "BMI at or above the 95th percentile for children of the same age and sex"
    },
    {
      "criterion": "pubertal",
      "label": "met",
      "evidence": "Testicular volume \u2265 6 ml Prader (M) and Tanner III breast development or greater (F)"
    },
    {
      "criterion": "age",
      "label": "met",
      "evidence": "12- 18 years regardless of gender, race or economic circumstance"
    },
    {
      "criterion": "pre diabetes/high risk of diabetes",
      "label": "met",
      "evidence": "HbA1C between 5.7 - 6.4% as defined by the American Diabetes Association (ADA)"
    },
    {
      "criterion": "25-OH vitamin D level less than 20 ng/ml",
      "label": "met",
      "evidence": "less than 20 ng/ml (50 nmol/liter)"
    },
    {
      "criterion": "willingness to comply with study protocol requirements",
      "label": "met",
      "evidence": "Subjects must be willing to comply with study protocol requirements"
    }
  ],
  "exclusion": [
    {
      "criterion": "treatment on medication known to effect vitamin D, calcium and glucose metabolism",
      "label": "unknown",
      "evidence": "glucocorticoids, thiazolidinediones, metformin, anticonvulsants metabolized through cytochrome P-450 (phenytoin, carbamazepine, phenobarbital, sodium valproate)"
    },
    {
      "criterion": "vitamin D supplementation",
      "label": "unknown",
      "evidence": "Subjects will be excluded from the study if they have taken any form of vitamin D supplementation greater than 400 IU daily in the preceding 3 months."
    },
    {
      "criterion": "significant major organ system illness",
      "label": "unknown",
      "evidence": "Significant major organ system illness"
    },
    {
      "criterion": "history of nephrolithiasis or hypercalcemia",
      "label": "unknown",
      "evidence": "History of nephrolithiasis or hypercalcemia"
    },
    {
      "criterion": "pregnancy",
      "label": "not_met",
      "evidence": "Females who are pregnant"
    },
    {
      "criterion": "significant psychiatric illness",
      "label": "unknown",
      "evidence": "Significant psychiatric illness: schizophrenia, bipolar disorder, active substance abuse, and uncontrolled major depression."
    },
    {
      "criterion": "attendance at tanning salon",
      "label": "not_met",
      "evidence": "Attendance at tanning salon"
    }
  ],
  "notes": "Patient is a 22yo F with systemic mastocytosis, presenting with flushing and tachycardia. She responded well to IV steroids and diphenydramine.",
  "_meta": {
    "topic_id": "10",
    "trial_id": "NCT02414529",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}